A detailed history of Baker Chad R transactions in Pfizer Inc stock. As of the latest transaction made, Baker Chad R holds 24,500 shares of PFE stock, worth $672,770. This represents 0.14% of its overall portfolio holdings.

Number of Shares
24,500
Previous 24,500 -0.0%
Holding current value
$672,770
Previous $685,000 3.5%
% of portfolio
0.14%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $861,839 - $976,320
-24,000 Reduced 49.48%
24,500 $959,000
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $1.27 Million - $1.82 Million
-47,000 Reduced 49.21%
48,500 $1.58 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $634,601 - $723,514
-16,496 Reduced 14.73%
95,500 $4.17 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $239,104 - $254,909
-7,250 Reduced 6.08%
111,996 $4.06 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $3.66 Million - $3.88 Million
-110,000 Reduced 47.98%
119,246 $4.32 Million
Q2 2017

Aug 14, 2017

BUY
N/A
229,246
229,246 $7.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Baker Chad R Portfolio

Follow Baker Chad R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

News

Stay updated on Baker Chad R with notifications on news.